Summary
When multiple synchronous lung tumours are identified, discrimination of multicentric lung cancers from intrapulmonary metastases by clinical findings is often difficult. We used genetic alterations in p53 gene as a discrimination marker of double primary lung cancers from single lung cancer with intrapulmonary metastasis. Twenty of 861 patients with primary lung cancer who underwent lung resection were selected as subjects because they showed synchronous double solid tumours of the same histological type in the unilateral lung without distant metastases. In addition, they had been diagnosed as lung carcinoma with intrapulmonary metastasis by clinical and histological findings. DNAs were extracted from paraffin-embedded tissue of paired tumours from these 20 patients. Exons 5–9 of the p53 gene were examined for genetic alterations in the tumours by polymerase chain reaction, single-strand conformation polymorphism analysis and subsequent DNA sequencing analysis. Three different patterns in the distribution of p53 mutations in double lung tumours were observed: [A] mutation in only one of the tumours (four cases), [B] different mutations in the tumours (two cases), and [C] same mutation in both tumours (one case). The cases of [A] or [B] patterns could be classified as double primary lung cancers, while the case of the [C] pattern was suggested to be lung cancer with intrapulmonary metastasis. These results suggested that the multicentric cancers were more frequent than the intrapulmonary metastatic cancers in double cancer cases.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Caamano, J., Ruggeri, B., Momiki, S., Sickler, A., Zhang, S. Y. & Klein-Szanto, A. J. P. (1991). Detection of p53 in primary lung tumors and non-small cell lung carcinoma cell lines. Am J Pathol 139: 839–845.
Chiba, I., Takahashi, T., Nau, M. M., D’Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D. L., Carbone, D., Piantadosi, S. & Koga, H. (1990). Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5: 1603–1610.
Chung, K. Y., Mukhopadhyay, T., Kim, J., Casson, A., Ro, J. Y., Goepfert, H., Hong, W. K. & Roth, J. A. (1993). Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53: 1676–1683.
Ferguson, M. K., DeMeester, T. R., DesLauriers, J., Little, A. G., Piraux, M. & Golomb, H. (1985). Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg 89: 378–385.
Gasparotto, D., Maestro, R., Barzan, L., Vukosavljevic, T., Doglioni, C., Sulfaro, S., Piccinin, S. & Boiocchi, M. (1995). Recurrences and second primary tumors in the head and neck region: differentiation by p53 mutation analysis. Ann Oncol 6: 933–939.
Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris, C. C. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878.
Habuchi, T., Takahashi, R., Yamada, H., Kakei, Y., Sugiyama, T. & Yoshida, O. (1993). Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 342: 1087–1088.
Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. (1991). p53 mutations in human cancers. Science 253: 49–53.
Kandioler, D., Dekan, G., End, A., Pasching, E., Buchmayer, H., Gnant, M., Langmann, F., Mannhalter, C., Eckersberger, F. & Wolner, E. (1996). Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors. J Thorac Cardiovasc Surg 111: 827–832.
Kishimoto, Y., Murakami, Y., Shiraishi, M., Hayashi, K. & Sekiya, T. (1992). Aberrations of the p53 tumor suppressor gene in human non-small cell lung carcinomas of the lung. Cancer Res 52: 4799–4804.
Kunitoh, H., Eguchi, K., Yamada, K., Tsuchiya, R., Kaneko, M., Moriyama, N. & Noguchi, M. (1992). Intrapulmonary sublesions detected before surgery in patients with lung cancer. Cancer 70: 1876–1879.
Li, Z. H., Zheng, J., Weiss, L. M. & Shibata, D. (1994). c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 144: 303–309.
Martini, N. & Melamed, M. R. (1975). Multiple primary lung cancers. J Thorac Cardiovasc Surg 70: 606–612.
Mathisen, D. J., Jensik, R. J., Faber, L. P. & Kittle, F. K. (1984). Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg 88: 502–510.
Mitsudomi, T., Steinberg, S. M., Nau, M. M., Carbone, D. D., Amico, D., Bodner, S., Oie, H. K., Linnoila, R. I., Mulshine, J. L. & Minna, J. D. (1992). p53 gene mutations in non small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171–180.
Mitsudomi, T., Yatabe, Y., Koshikawa, T., Hatooka, S., Shinoda, M., Suyama, M., Sugiura, T., Ogawa, M. & Takahashi, T. (1997). Mutations of the p53 tumor suppressor gene as clonal marker for multiple primary lung cancers. J Thorac Cardiovasc Surg 114: 354–360.
Mok, C. H., Tsao, S. W., Knapp, R. C., Fishbaugh, P. M. & Lau, C. C. (1992). Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res 52: 5119–5122.
Nakajima, J., Furuse, A., Oka, T., Kohno, T. & Ohtsuka, T. (1996). Excellent survival in a subgroup of patients with intrapulmonary metastasis of lung cancer. Ann Thorac Surg 61: 158–163.
Naruke, T., Goya, T., Tsuchiya, R. & Suemasu, K. (1988). Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96: 440–447.
Nees, M., Homann, N., Discher, H., Andl, T., Enders, C., Herold, M. C., Schuhmann, A. & Bosch, F. X. (1993). Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 53: 4189–4196.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M. & Hirohashi, S. (1992). Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res 52: 3674–3678.
Reichel, M. B., Ohgaki, H., Petersen, I. & Kleihues, P. (1994). p53 mutations in primary human lung tumors and their metastases. Mol Carcinog 9: 105–109.
Schlegel, U., Rosenfeld, M. R., Volkenandt, M., Rosenblum, M., Dalmau, J. & Furneaux, H. (1992). p53 gene mutations in primary lung tumors are conserved in brain metastases. J Neurooncol 14: 93–100.
Sozzi, G., Miozzo, M., Pastorino, U., Pilotti, S., Donghi, R., Giarola, M., Gregorio, L. D., Manenti, G., Radice, P., Minoletti, F., Porta, G. D. & Pierotti, M. A. (1995). Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 55: 135–140.
Taylor, J. A., Watson, M. A., Devereux, T. R., Michels, R. Y., Saccomanno, G. & Anderson, M. (1994). p53 mutation hotspot in radon-associated lung cancer. Lancet 343: 86–87.
Yokota, J. & Sugimura, T. (1993). Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J 7: 920–925.
Zheng, J., Shu, Q., Li, Z. H., Tsao, J. I., Weiss, L. M. & Shibata, D. (1994). Patterns of p53 mutations in squamous cell carcinoma of the lung. Am J Pathol 145: 1444–1449.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Matsuzoe, D., Hideshima, T., Ohshima, K. et al. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer 79, 1549–1552 (1999). https://doi.org/10.1038/sj.bjc.6690247
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690247
Keywords
This article is cited by
-
The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report
World Journal of Surgical Oncology (2017)
-
Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review
Journal of Experimental & Clinical Cancer Research (2015)
-
“Different trend” in multiple primary lung cancer and intrapulmonary metastasis
European Journal of Medical Research (2015)
-
Clinical features of multiple lung cancers based on thin-section computed tomography: What are the appropriate surgical strategies for second lung cancers?
Surgery Today (2015)
-
Diagnosis of metachronous multiple lung adenocarcinoma at the cut-end by epidermal growth factor receptor mutation status discordance 4 years after sublobar resection for adenocarcinoma in situ: report of a case
Surgery Today (2015)